Clinical Misdiagnosis of Cutaneous Malignant Tumors as Melanocytic Nevi or Seborrheic Keratosis: A Retrospective Analysis of a Chinese Population
Jun Zhang,Yu Wang,Wei Zhang,Linglong Cai,Jianglong Feng,Yiwei Zhu,Hongguang Lu
DOI: https://doi.org/10.2147/ccid.s451288
2024-02-26
Clinical Cosmetic and Investigational Dermatology
Abstract:Jun Zhang, 1 Yu Wang, 1 Wei Zhang, 1 Linglong Cai, 1 Jianglong Feng, 2 Yiwei Zhu, 1 Hongguang Lu 1 1 Department of Dermatology, the Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China; 2 Department of Pathology, the Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China Correspondence: Hongguang Lu, Department of Dermatology, the Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Street, Guiyang, Guizhou, 550001, People's Republic of China, Tel +86-13885144269, Fax +86-851-86820346, Email ; Purpose: The rising incidence and mortality associated with cutaneous malignant tumours highlight the importance of early diagnosis of these tumors. In clinical practice, these tumors are often misdiagnosed as benign skin lesions such as melanocytic nevi (MN) and seborrheic keratosis (SK) because of their similar morphologic features. The incidence and clinicopathological subtypes of cutaneous malignancies in East Asia populations significantly differ from those in fair-skinned groups. However, studies on misdiagnoses in Eastern countries are lacking. Therefore, this study focused on the clinical and pathological features of cutaneous malignant tumors misdiagnosed as MN or SK in a Chinese population. Patients and Methods: A total of 4592 samples clinically diagnosed as MN (n = 3503) or SK (n = 1089) from July 2014 to June 2022 were collected and evaluated retrospectively. The clinical and pathological data were analyzed to identify associated factors. Results: Pathological assessments showed that 2.5% (86/3503) of the specimens clinically diagnosed as MN were malignancies, predominantly basal cell carcinoma (BCC, 84.9%, 73/86), followed by malignant melanoma (MM, 8.1%, 7/86) and squamous cell carcinoma (SCC, 7.0%, 6/86). Similarly, 5.7% (62/1089) of the specimens clinically diagnosed as SK were malignant tumors, of which BCC (50.0%, 31/62) was the most common, followed by SCC (41.9%, 26/62) and MM (8.1%, 5/62). In both types of specimens, advanced age and facial lesions were risk factors for malignancy misdiagnosis. The malignancy rate, mean age, and proportion of SCC in the specimens clinically diagnosed as SK were higher than those in the specimens clinically diagnosed as MN. Dermoscopy significantly reduced the rate of misdiagnosis of these tumors as MN or SK. Conclusion: In China, cutaneous malignant tumors misdiagnosed as MN or SK are not uncommon in clinical practice, and active introduction of noninvasive diagnostic techniques is essential to distinguish them. Keywords: malignant melanoma, squamous cell carcinoma, basal cell carcinoma, skin benign neoplasms, dermoscopy, China The growing prevalence of skin tumors, especially cutaneous malignant tumors, poses a prominent public health challenge worldwide, and has attracted attention from clinicians and researchers. 1,2 Early diagnosis is fundamental to reduce the complications and mortality associated with malignant tumors. 3 However, cutaneous malignant tumors are frequently misdiagnosed as melanocytic nevi (MN) or seborrheic keratosis (SK), and the misdiagnosis rate is not low. 4–8 In particular, special attention should be given to malignant melanoma (MM), the most lethal type of skin cancer, which is often misdiagnosed as MN or SK. 4–6,9 MN and SK are the two most prevalent benign neoplasms in dermatology. 10–12 In China, many patients with MN or SK visit dermatologists because of concerns regarding malignancy or cosmetic needs, 4 and clinicians in primary hospitals and even some tertiary hospitals habitually use minimally invasive methods such as laser treatment or cryotherapy to treat those conditions, which may result in misdiagnosis and inappropriate treatment of malignant tumors. The prevalence and clinicopathologic features of skin cancer vary markedly across different races or skin types. 1,13 Previous studies on the misdiagnosis of skin cancer were mainly conducted in Western countries, with a notable gap in research from East Asia. 13 This study aimed to identify the risk factors for misdiagnosis of cutaneous malignant tumors as MN or SK in the Chinese population by using data obtained from a tertiary teaching hospital in China from July 2014 to June 2022, to guide clinical practices and reduce misdiagnoses in similar demographic groups. This retrospective study examined all surgical and biopsy specimens initially diagnosed as MN or SK at the Department of Dermatology in the Affiliated Hospital of Guizhou Medical University (Guizhou Province, China) from July 2014 to June 2022. The specimens were subjected to pathologica -Abstract Truncated-
dermatology